TRENQUET Trademark

Trademark Overview


On Tuesday, February 25, 2020, a trademark application was filed for TRENQUET with the United States Patent and Trademark Office. The USPTO has given the TRENQUET trademark a serial number of 88809992. The federal status of this trademark filing is REGISTERED as of Tuesday, May 4, 2021. This trademark is owned by Glaxo Group Limited. The TRENQUET trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
trenquet

General Information


Serial Number88809992
Word MarkTRENQUET
Filing DateTuesday, February 25, 2020
Status700 - REGISTERED
Status DateTuesday, May 4, 2021
Registration Number6338002
Registration DateTuesday, May 4, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 16, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 28, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 4, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, February 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 16, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 11, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 12, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, November 12, 2020LETTER OF SUSPENSION E-MAILED
Thursday, November 12, 2020SUSPENSION LETTER WRITTEN
Tuesday, November 10, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 9, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 9, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 12, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 12, 2020NON-FINAL ACTION E-MAILED
Tuesday, May 12, 2020NON-FINAL ACTION WRITTEN
Thursday, May 7, 2020ASSIGNED TO EXAMINER
Friday, February 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 28, 2020NEW APPLICATION ENTERED IN TRAM